Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

In Defense of Baseline Genotypic Antiretroviral Resistance Testing.

Lang R, Krentz HB, Gill MJ.

J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):e1-e2. doi: 10.1097/QAI.0000000000002210. No abstract available.

PMID:
31809365
2.

The Impact of "Churn" on Plasma HIV Burden Within a Population Under Care.

Krentz HB, Vu Q, Gill MJ.

Open Forum Infect Dis. 2019 Apr 26;6(6):ofz203. doi: 10.1093/ofid/ofz203. eCollection 2019 Jun.

3.

Desimplification of Single Tablet Antiretroviral (ART) Regimens-A Practical Cost-Savings Strategy?

Krentz H, Campbell S, Gill J.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958218822304. doi: 10.1177/2325958218822304.

4.

De-simplifying single-tablet antiretroviral treatments: uptake, risks and cost savings.

Krentz HB, Campbell S, Lahl M, Gill MJ.

HIV Med. 2019 Mar;20(3):214-221. doi: 10.1111/hiv.12701. Epub 2019 Jan 11.

PMID:
30632660
5.

Managing HIV infection in patients older than 50 years.

McMillan JM, Krentz H, Gill MJ, Hogan DB.

CMAJ. 2018 Oct 22;190(42):E1253-E1258. doi: 10.1503/cmaj.171409. Review. No abstract available.

6.

A retrospective study of the clinical features of new syphilis infections in an HIV-positive cohort in Alberta, Canada.

Lang R, Read R, Krentz HB, Peng M, Ramazani S, Vu Q, Gill MJ.

BMJ Open. 2018 Jul 10;8(7):e021544. doi: 10.1136/bmjopen-2018-021544.

7.

Long-term HIV/AIDS survivors: Patients living with HIV infection retained in care for over 20 years. What have we learned?

Krentz HB, John Gill M.

Int J STD AIDS. 2018 Nov;29(11):1098-1105. doi: 10.1177/0956462418778705. Epub 2018 Jun 22.

PMID:
29933720
8.

Increasing incidence of syphilis among patients engaged in HIV care in Alberta, Canada: a retrospective clinic-based cohort study.

Lang R, Read R, Krentz HB, Ramazani S, Peng M, Gratrix J, Gill MJ.

BMC Infect Dis. 2018 Mar 13;18(1):125. doi: 10.1186/s12879-018-3038-4.

9.

Patient perspectives on de-simplifying their single-tablet co-formulated antiretroviral therapy for societal cost savings.

Krentz HB, Campbell S, Gill VC, Gill MJ.

HIV Med. 2018 Apr;19(4):290-298. doi: 10.1111/hiv.12578. Epub 2018 Jan 25.

PMID:
29368401
10.

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.

Lodi S, Costagliola D, Sabin C, Del Amo J, Logan R, Abgrall S, Reiss P, van Sighem A, Jose S, Blanco JR, Hernando V, Bucher HC, Kovari H, Segura F, Ambrosioni J, Gogos CA, Pantazis N, Dabis F, Vandenhende MA, Meyer L, Seng R, Gill MJ, Krentz H, Phillips AN, Porter K, Grinsztejn B, Pacheco AG, Muga R, Tate J, Justice A, Hernán MA.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):311-318. doi: 10.1097/QAI.0000000000001498.

11.

Healthcare contacts among patients lost to follow-up in HIV care: review of a large regional cohort utilizing electronic health records.

Connors WJ, Krentz HB, Gill MJ.

Int J STD AIDS. 2017 Nov;28(13):1275-1281. doi: 10.1177/0956462417699464. Epub 2017 Mar 17.

PMID:
28632480
12.

Reporting on the prevalence of antiretroviral drug resistance in a regional HIV population over 20 years: a word of caution.

Gill VC, Lynch T, Ramazani S, Krentz HB.

Antivir Ther. 2017;22(4):277-286. doi: 10.3851/IMP3105. Epub 2016 Nov 2.

PMID:
27805572
13.

Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care.

Hoehn N, Gill MJ, Krentz HB.

AIDS Care. 2017 May;29(5):564-569. doi: 10.1080/09540121.2016.1234678. Epub 2016 Sep 18.

PMID:
27642701
14.

Using token reinforcement to increase walking for adults with intellectual disabilities.

Krentz H, Miltenberger R, Valbuena D.

J Appl Behav Anal. 2016 Dec;49(4):745-750. doi: 10.1002/jaba.326. Epub 2016 Jun 10.

PMID:
27287667
15.

Maintaining the continuity of HIV-care records for patients transferring care between centers: challenges, workloads, needs and risks.

Gill MJ, Ody M, Lynch T, Jessiman-Perreault L, Krentz HB.

AIDS Care. 2016 Aug;28(8):1073-8. doi: 10.1080/09540121.2016.1139042. Epub 2016 Feb 1.

PMID:
26829326
16.

Mortality in migrants with HIV in western Europe.

Gill MJ, Krentz HB.

Lancet HIV. 2015 Dec;2(12):e508-9. doi: 10.1016/S2352-3018(15)00210-6. Epub 2015 Nov 18. No abstract available.

PMID:
26614963
17.

The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients.

Krentz HB, Gill MJ.

AIDS Patient Care STDS. 2016 Jan;30(1):11-7. doi: 10.1089/apc.2015.0199. Epub 2015 Nov 6.

PMID:
26544766
18.

Patient Perspectives on Leaving, Disengaging, and Returning to HIV Care.

Gill VC, Krentz HB.

AIDS Patient Care STDS. 2015 Jul;29(7):400-7. doi: 10.1089/apc.2015.0001. Epub 2015 Jun 11.

PMID:
26065908
19.

High Mortality Among Human Immunodeficiency Virus (HIV)-Infected Individuals Before Accessing or Linking to HIV Care: A Missing Outcome in the Cascade of Care?

Krentz HB, MacDonald J, John Gill M.

Open Forum Infect Dis. 2014 May 7;1(1):ofu011. doi: 10.1093/ofid/ofu011. eCollection 2014 Mar.

20.

Implementing an intimate partner violence (IPV) screening protocol in HIV care.

Raissi SE, Krentz HB, Siemieniuk RA, Gill MJ.

AIDS Patient Care STDS. 2015 Mar;29(3):133-41. doi: 10.1089/apc.2014.0306. Epub 2015 Jan 13.

PMID:
25585198
21.

The impact of transfer patients on the local cascade of HIV care continuum.

Krentz HB, MacDonald J, Gill MJ.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):236-40. doi: 10.1097/QAI.0000000000000430.

PMID:
25394193
22.

Increased costs of HIV care associated with aging in an HIV-infected population.

Krentz HB, Gill MJ.

HIV Med. 2015 Jan;16(1):38-47. doi: 10.1111/hiv.12176. Epub 2014 Aug 8.

23.

The cost of antiretroviral drug resistance in HIV-positive patients.

Krentz HB, Ko K, Beckthold B, Gill MJ.

Antivir Ther. 2014;19(4):341-8. doi: 10.3851/IMP2709. Epub 2013 Dec 3.

PMID:
24296618
24.

The effect of churn on "community viral load" in a well-defined regional population.

Krentz HB, Gill MJ.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):190-6. doi: 10.1097/QAI.0b013e31829cef18.

PMID:
24047969
25.

Bacteriology swabs in primary total knee arthroplasty.

Haenle M, Podbielski A, Ellenrieder M, Mundt A, Krentz H, Mittelmeier W, Skripitz R.

GMS Hyg Infect Control. 2013 Apr 29;8(1):Doc02. doi: 10.3205/dgkh000202. eCollection 2013.

26.

Intimate partner violence and HIV: a review.

Siemieniuk RA, Krentz HB, Gill MJ.

Curr HIV/AIDS Rep. 2013 Dec;10(4):380-9. doi: 10.1007/s11904-013-0173-9. Review.

PMID:
23943348
27.

Centre-based statistics of cleft lip with/without alveolus and palate as well as cleft palate only patients in Aden, Yemen.

Esmail AH, Abdo MA, Krentz H, Lenz JH, Gundlach KK.

J Craniomaxillofac Surg. 2014 Jun;42(4):297-304. doi: 10.1016/j.jcms.2013.05.030. Epub 2013 Jul 9.

PMID:
23849245
29.

The clinical implications of high rates of intimate partner violence against HIV-positive women.

Siemieniuk RA, Krentz HB, Miller P, Woodman K, Ko K, Gill MJ.

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):32-8. doi: 10.1097/QAI.0b013e31829bb007.

PMID:
23714742
30.

Retention among North American HIV-infected persons in clinical care, 2000-2008.

Rebeiro P, Althoff KN, Buchacz K, Gill J, Horberg M, Krentz H, Moore R, Sterling TR, Brooks JT, Gebo KA, Hogg R, Klein M, Martin J, Mugavero M, Rourke S, Silverberg MJ, Thorne J, Gange SJ; North American AIDS Cohort Collaboration on Research and Design.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):356-62. doi: 10.1097/QAI.0b013e31827f578a.

31.

Prevalence, clinical associations, and impact of intimate partner violence among HIV-infected gay and bisexual men: a population-based study.

Siemieniuk RA, Miller P, Woodman K, Ko K, Krentz HB, Gill MJ.

HIV Med. 2013 May;14(5):293-302. doi: 10.1111/hiv.12005. Epub 2012 Nov 21.

32.

A novel sialyl Le(X) expression score as a potential prognostic tool in colorectal cancer.

Schiffmann L, Schwarz F, Linnebacher M, Prall F, Pahnke J, Krentz H, Vollmar B, Klar E.

World J Surg Oncol. 2012 May 23;10:95. doi: 10.1186/1477-7819-10-95.

33.

Pill burden in HIV infection: 20 years of experience.

Krentz HB, Cosman I, Lee K, Ming JM, Gill MJ.

Antivir Ther. 2012;17(5):833-40. doi: 10.3851/IMP2076. Epub 2012 Feb 23.

PMID:
22358155
34.

The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period.

Krentz HB, Gill MJ.

AIDS Res Treat. 2012;2012:757135. doi: 10.1155/2012/757135. Epub 2011 Aug 29.

35.

Comparison of healthcare costs between local and immigrant HIV populations living in Southern Alberta, Canada.

Krentz HB, Gill MJ.

Health Policy. 2011 Dec;103(2-3):124-9. doi: 10.1016/j.healthpol.2011.08.003. Epub 2011 Sep 3.

PMID:
21893362
36.

Experiments on the mechanism of underwater hearing.

Pau HW, Warkentin M, Specht O, Krentz H, Herrmann A, Ehrt K.

Acta Otolaryngol. 2011 Dec;131(12):1279-85. doi: 10.3109/00016489.2011.607845. Epub 2011 Sep 5.

PMID:
21888565
37.

On the variability in preterm birth rate, birth weight, and somatic classification among neonates of mothers with the same body mass index.

Krentz H, Voigt M, Guthmann F, Hesse V, Straube S.

Z Geburtshilfe Neonatol. 2011 Aug;215(4):163-6. doi: 10.1055/s-0031-1285847. Epub 2011 Aug 23.

PMID:
21863531
38.

Effect of alcohol consumption on whole-body protein turnover in healthy adults.

Wutzke KD, Krentz H, Bruns G.

Isotopes Environ Health Stud. 2011 Mar;47(1):26-33. doi: 10.1080/10256016.2011.557724.

PMID:
21390988
39.

Adverse health effects for individuals who move between HIV care centers.

Krentz HB, Worthington H, Gill MJ.

J Acquir Immune Defic Syndr. 2011 May 1;57(1):51-4. doi: 10.1097/QAI.0b013e318214feee.

PMID:
21346587
40.

Domestic violence screening: prevalence and outcomes in a Canadian HIV population.

Siemieniuk RA, Krentz HB, Gish JA, Gill MJ.

AIDS Patient Care STDS. 2010 Dec;24(12):763-70. doi: 10.1089/apc.2010.0235.

PMID:
21138382
41.

Monitoring and adjusting for future needs in response to changing HIV policies.

Krentz HB, Gill J.

Lancet Infect Dis. 2010 Oct;10(10):671-2. doi: 10.1016/S1473-3099(10)70213-9. No abstract available.

PMID:
20883965
43.

Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study.

Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, Power C.

Neurology. 2010 Sep 28;75(13):1150-8. doi: 10.1212/WNL.0b013e3181f4d5bb. Epub 2010 Aug 25.

44.

Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS.

Lee K, Vivithanaporn P, Siemieniuk RA, Krentz HB, Maingat F, Gill MJ, Power C.

BMC Neurol. 2010 Jun 17;10:44. doi: 10.1186/1471-2377-10-44.

45.

Unappreciated epidemiology: the churn effect in a regional HIV care programme.

Gill MJ, Krentz HB.

Int J STD AIDS. 2009 Aug;20(8):540-4. doi: 10.1258/ijsa.2008.008422.

PMID:
19625584
46.

The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes in a regional Canadian HIV population.

Krentz H, Gill MJ.

Health Policy. 2009 May;90(2-3):296-302. doi: 10.1016/j.healthpol.2008.09.016. Epub 2008 Nov 20.

PMID:
19022519
47.

Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.

Krentz HB, Gill MJ.

HIV Med. 2008 Oct;9(9):721-30. doi: 10.1111/j.1468-1293.2008.00613.x. Epub 2008 Jul 17.

48.

[Results from a survey of intensive care training. How much that is learned applies to later practice?].

Stöwhas M, Foitzik T, Krentz H, Klar E.

Chirurg. 2008 Jul;79(7):665-70. doi: 10.1007/s00104-008-1513-y. German.

PMID:
18431557
49.

Similar challenges with retention in care issues.

Krentz HB, Siemieniuk RA, Gill MJ.

Clin Infect Dis. 2007 Dec 1;45(11):1527. No abstract available.

PMID:
17990241
50.

Impact of expanded HIV screening.

Krentz HB, Gill MJ.

Ann Intern Med. 2007 Jul 17;147(2):146; author reply 146-7. No abstract available.

PMID:
17638723

Supplemental Content

Loading ...
Support Center